SYBN:F:F-SPDR Barclays 10+ U.S. Corporate Bond UCITS (EUR)

ETF | Others |

Last Closing

USD 25.59

Change

0.00 (0.00)%

Market Cap

USD 0.10B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.50 (+1.85%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.88 (+1.73%)

USD 115.53B
SXR8:F iShares Core S&P 500 UCITS ETF..

+5.96 (+1.09%)

USD 96.59B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.98 (+1.78%)

USD 94.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+4.25 (+1.78%)

USD 57.94B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 54.05B
VUAA:F Vanguard S&P 500 UCITS Acc

+1.41 (+1.45%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+1.21 (+1.24%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

-0.09 (-1.11%)

USD 40.74B
0ZC:F Zscaler Inc

+0.20 (+0.13%)

USD 37.92B

ETFs Containing SYBN:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.63% 19% F 44% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.63% 16% F 38% F
Trailing 12 Months  
Capital Gain 12.19% 42% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.19% 38% F 47% F
Trailing 5 Years  
Capital Gain -21.14% 5% F 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -21.14% 5% F 19% F
Average Annual (5 Year Horizon)  
Capital Gain -6.22% N/A N/A 29% F
Dividend Return -6.22% N/A N/A 26% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 6.78% N/A N/A 95% A
Risk Adjusted Return -91.74% N/A N/A 2% F
Market Capitalization 0.10B 27% F 31% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.